Cantargia appoints Morten Lind Jensen as Chief Medical Officer https://lnkd.in/d6wUHDrv
Cantargia AB
Forskning inom bioteknik
Lund, Skåne County 3 422 följare
A Swedish listed biotechnology company
Om oss
Cantargia develops antibody based therapies against the target IL1RAP. The two clinical programs are nadunolimab in phase II development for treatment of cancer, and CAN10 in phase I development for autoimmune/inflammatory diseases.
- Webbplats
-
http://www.cantargia.com
Extern länk för Cantargia AB
- Bransch
- Forskning inom bioteknik
- Företagsstorlek
- 11–50 anställda
- Huvudkontor
- Lund, Skåne County
- Typ
- Publikt aktiebolag
- Grundat
- 2010
Adresser
-
Primär
Få vägbeskrivning
Scheelevägen 27
Lund, Skåne County 22363, SE
Anställda på Cantargia AB
Uppdateringar
-
Interview with Interim CEO Damian Marron during the H.C. Wainwright 3rd Annual Autoimmune & Inflammatory Disease Virtual Conference. https://lnkd.in/d7pndqJU
-
First patient enrolled in Cantargia’s leukemia study with nadunolimab. https://lnkd.in/dfH6bQjx
-
Cantargia to Participate at H.C. Wainwright’s Annual Autoimmune & Inflammatory Virtual Conference More information: https://lnkd.in/dEZd3v5B Live webcasting link: https://lnkd.in/d7pndqJU
-
Cantargia reports promising CAN10 phase 1 data from first multiple dose cohort, and FDA and Key Opinion Leader feedback https://lnkd.in/gfnYVs_b
-
-
Redeye interviews Interim CEO Damian Marron. Watch the interview here: https://lnkd.in/dPH5rnh4
-
We are pleased to announce the appointment of Damian Marron as Cantargia’s interim CEO while the board searches for a new CEO to lead Cantargia into the next phase of development and value creation. https://lnkd.in/eFrPFx63
-
CEO Göran Forsberg presented at Redeye Fight Cancer Event. Watch the presentation here https://lnkd.in/dMU7XT5Y
-
Biostock interviews CEO Göran Forsberg. https://lnkd.in/dfhi7VEZ #Cantargia #IL1RAP #Nadunolimab #CAN10
-
Redeye interviews CEO Göran Forsberg about the expansion of CAN10's phase 1 study with new dose groups. See the the interview in Swedish here: https://lnkd.in/dSeaCYSv #Cantargia #CAN10 #Unnflammation #Autoimmunity
Liknande sidor
Finansiering
Cantargia AB
2 rundor totalt
Se mer info på crunchbase
Senaste finansieringsrunda
Aktiekapital efter börsintroduktion
Extern Crunchbase Link för sista finansieringsrundan
24 732 395,00 US$